Packaged Foods
Compare Stocks
4 / 10Stock Comparison
JBSS vs IPAR vs EL vs FRPT
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Packaged Foods
JBSS vs IPAR vs EL vs FRPT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Packaged Foods | Household & Personal Products | Household & Personal Products | Packaged Foods |
| Market Cap | $913M | $3.01B | $30.80B | $2.74B |
| Revenue (TTM) | $1.14B | $1.49B | $14.84B | $1.14B |
| Net Income (TTM) | $70M | $201M | $-248M | $200M |
| Gross Margin | 19.1% | 64.0% | 74.7% | 38.9% |
| Operating Margin | 8.9% | 18.0% | 6.8% | 8.8% |
| Forward P/E | 10.7x | 19.4x | 38.4x | 41.1x |
| Total Debt | $102M | $224M | $9.44B | $560M |
| Cash & Equiv. | $585K | $158M | $2.92B | $278M |
JBSS vs IPAR vs EL vs FRPT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| John B. Sanfilippo … (JBSS) | 100 | 89.8 | -10.2% |
| Inter Parfums, Inc. (IPAR) | 100 | 202.5 | +102.5% |
| The Estée Lauder Co… (EL) | 100 | 43.2 | -56.8% |
| Freshpet, Inc. (FRPT) | 100 | 72.4 | -27.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: JBSS vs IPAR vs EL vs FRPT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
JBSS is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.31, Low D/E 28.3%, current ratio 2.22x
- Beta 0.31 vs EL's 1.73, lower leverage
IPAR carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.54, yield 3.4%
- 255.2% 10Y total return vs FRPT's 5.2%
- PEG 0.57 vs JBSS's 7.58
- Beta 0.54, yield 3.4%, current ratio 2.99x
EL is the clearest fit if your priority is momentum.
- +46.3% vs FRPT's -31.1%
FRPT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 13.0%, EPS growth 183.9%, 3Y rev CAGR 22.8%
- 13.0% revenue growth vs EL's -8.5%
- 17.6% margin vs EL's -1.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.0% revenue growth vs EL's -8.5% | |
| Value | Lower P/E (19.4x vs 41.1x) | |
| Quality / Margins | 17.6% margin vs EL's -1.7% | |
| Stability / Safety | Beta 0.31 vs EL's 1.73, lower leverage | |
| Dividends | 3.4% yield, 5-year raise streak, vs JBSS's 2.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +46.3% vs FRPT's -31.1% | |
| Efficiency (ROA) | 12.9% ROA vs EL's -1.3%, ROIC 18.6% vs 6.5% |
JBSS vs IPAR vs EL vs FRPT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
JBSS vs IPAR vs EL vs FRPT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FRPT leads in 2 of 6 categories
JBSS leads 2 • IPAR leads 2 • EL leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
FRPT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EL is the larger business by revenue, generating $14.8B annually — 13.1x FRPT's $1.1B. FRPT is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to EL's -1.7%. On growth, FRPT holds the edge at +13.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $1.5B | $14.8B | $1.1B |
| EBITDAEarnings before interest/tax | $127M | $291M | $1.6B | $165M |
| Net IncomeAfter-tax profit | $70M | $201M | -$248M | $200M |
| Free Cash FlowCash after capex | $33M | $199M | $1.3B | $223M |
| Gross MarginGross profit ÷ Revenue | +19.1% | +64.0% | +74.7% | +38.9% |
| Operating MarginEBIT ÷ Revenue | +8.9% | +18.0% | +6.8% | +8.8% |
| Net MarginNet income ÷ Revenue | +6.2% | +13.5% | -1.7% | +17.6% |
| FCF MarginFCF ÷ Revenue | +2.9% | +13.3% | +8.7% | +19.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.6% | +1.8% | +4.6% | +13.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.9% | +2.3% | -45.5% | +4.5% |
Valuation Metrics
JBSS leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 15.5x trailing earnings, JBSS trades at a 27% valuation discount to FRPT's 21.2x P/E. Adjusting for growth (PEG ratio), IPAR offers better value at 0.53x vs JBSS's 11.02x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $913M | $3.0B | $30.8B | $2.7B |
| Enterprise ValueMkt cap + debt − cash | $1.0B | $3.1B | $37.3B | $3.0B |
| Trailing P/EPrice ÷ TTM EPS | 15.53x | 17.93x | -27.08x | 21.16x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.68x | 19.38x | 38.44x | 41.11x |
| PEG RatioP/E ÷ EPS growth rate | 11.02x | 0.53x | — | — |
| EV / EBITDAEnterprise value multiple | 8.73x | 11.33x | 20.88x | 16.62x |
| Price / SalesMarket cap ÷ Revenue | 0.82x | 2.02x | 2.16x | 2.49x |
| Price / BookPrice ÷ Book value/share | 2.54x | 2.74x | 7.95x | 2.59x |
| Price / FCFMarket cap ÷ FCF | — | 15.80x | 45.97x | 221.45x |
Profitability & Efficiency
IPAR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
JBSS delivers a 19.5% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-6 for EL. IPAR carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to EL's 2.44x. On the Piotroski fundamental quality scale (0–9), FRPT scores 6/9 vs JBSS's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.5% | +18.4% | -6.3% | +17.0% |
| ROA (TTM)Return on assets | +11.7% | +12.9% | -1.3% | +11.4% |
| ROICReturn on invested capital | +15.2% | +18.6% | +6.5% | +5.3% |
| ROCEReturn on capital employed | +20.4% | +23.3% | +6.3% | +6.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.28x | 0.20x | 2.44x | 0.46x |
| Net DebtTotal debt minus cash | $102M | $66M | $6.5B | $282M |
| Cash & Equiv.Liquid assets | $585,000 | $158M | $2.9B | $278M |
| Total DebtShort + long-term debt | $102M | $224M | $9.4B | $560M |
| Interest CoverageEBIT ÷ Interest expense | 26.02x | 50.40x | 1.14x | 13.29x |
Total Returns (Dividends Reinvested)
FRPT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IPAR five years ago would be worth $14,188 today (with dividends reinvested), compared to $3,165 for FRPT. Over the past 12 months, EL leads with a +46.3% total return vs FRPT's -31.1%. The 3-year compound annual growth rate (CAGR) favors FRPT at -6.2% vs EL's -23.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.1% | +10.9% | -19.8% | -7.1% |
| 1-Year ReturnPast 12 months | +39.3% | -18.8% | +46.3% | -31.1% |
| 3-Year ReturnCumulative with dividends | -22.9% | -32.7% | -55.6% | -17.4% |
| 5-Year ReturnCumulative with dividends | +4.0% | +41.9% | -68.3% | -68.4% |
| 10-Year ReturnCumulative with dividends | +101.1% | +255.2% | +10.8% | +517.3% |
| CAGR (3Y)Annualised 3-year return | -8.3% | -12.4% | -23.7% | -6.2% |
Risk & Volatility
JBSS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
JBSS is the less volatile stock with a 0.31 beta — it tends to amplify market swings less than EL's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JBSS currently trades 91.7% from its 52-week high vs FRPT's 62.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.31x | 0.54x | 1.73x | 0.91x |
| 52-Week HighHighest price in past year | $85.15 | $142.61 | $121.64 | $89.80 |
| 52-Week LowLowest price in past year | $58.47 | $77.21 | $57.91 | $46.76 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +65.9% | +70.1% | +62.2% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 55.9 | 66.6 | 29.1 |
| Avg Volume (50D)Average daily shares traded | 80K | 259K | 4.6M | 1.5M |
Analyst Outlook
IPAR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JBSS as "Buy", IPAR as "Hold", EL as "Hold", FRPT as "Buy". Consensus price targets imply 31.4% upside for FRPT (target: $73) vs 14.4% for IPAR (target: $108). For income investors, IPAR offers the higher dividend yield at 3.40% vs EL's 2.01%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $107.50 | $106.73 | $73.42 |
| # AnalystsCovering analysts | 2 | 19 | 46 | 29 |
| Dividend YieldAnnual dividend ÷ price | +2.7% | +3.4% | +2.0% | — |
| Dividend StreakConsecutive years of raises | 0 | 5 | 0 | — |
| Dividend / ShareAnnual DPS | $2.08 | $3.20 | $1.72 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +0.5% | +0.1% | 0.0% |
FRPT leads in 2 of 6 categories (Income & Cash Flow, Total Returns). JBSS leads in 2 (Valuation Metrics, Risk & Volatility).
JBSS vs IPAR vs EL vs FRPT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is JBSS or IPAR or EL or FRPT a better buy right now?
For growth investors, Freshpet, Inc.
(FRPT) is the stronger pick with 13. 0% revenue growth year-over-year, versus -8. 5% for The Estée Lauder Companies Inc. (EL). John B. Sanfilippo & Son, Inc. (JBSS) offers the better valuation at 15. 5x trailing P/E (10. 7x forward), making it the more compelling value choice. Analysts rate John B. Sanfilippo & Son, Inc. (JBSS) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — JBSS or IPAR or EL or FRPT?
On trailing P/E, John B.
Sanfilippo & Son, Inc. (JBSS) is the cheapest at 15. 5x versus Freshpet, Inc. at 21. 2x. On forward P/E, John B. Sanfilippo & Son, Inc. is actually cheaper at 10. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Inter Parfums, Inc. wins at 0. 57x versus John B. Sanfilippo & Son, Inc. 's 7. 58x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — JBSS or IPAR or EL or FRPT?
Over the past 5 years, Inter Parfums, Inc.
(IPAR) delivered a total return of +41. 9%, compared to -68. 4% for Freshpet, Inc. (FRPT). Over 10 years, the gap is even starker: FRPT returned +517. 3% versus EL's +10. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — JBSS or IPAR or EL or FRPT?
By beta (market sensitivity over 5 years), John B.
Sanfilippo & Son, Inc. (JBSS) is the lower-risk stock at 0. 31β versus The Estée Lauder Companies Inc. 's 1. 73β — meaning EL is approximately 455% more volatile than JBSS relative to the S&P 500. On balance sheet safety, Inter Parfums, Inc. (IPAR) carries a lower debt/equity ratio of 20% versus 2% for The Estée Lauder Companies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — JBSS or IPAR or EL or FRPT?
By revenue growth (latest reported year), Freshpet, Inc.
(FRPT) is pulling ahead at 13. 0% versus -8. 5% for The Estée Lauder Companies Inc. (EL). On earnings-per-share growth, the picture is similar: Freshpet, Inc. grew EPS 183. 9% year-over-year, compared to -391. 7% for The Estée Lauder Companies Inc.. Over a 3-year CAGR, FRPT leads at 22. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — JBSS or IPAR or EL or FRPT?
Freshpet, Inc.
(FRPT) is the more profitable company, earning 12. 6% net margin versus -7. 9% for The Estée Lauder Companies Inc. — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IPAR leads at 18. 2% versus 6. 7% for EL. At the gross margin level — before operating expenses — EL leads at 73. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is JBSS or IPAR or EL or FRPT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Inter Parfums, Inc. (IPAR) is the more undervalued stock at a PEG of 0. 57x versus John B. Sanfilippo & Son, Inc. 's 7. 58x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, John B. Sanfilippo & Son, Inc. (JBSS) trades at 10. 7x forward P/E versus 41. 1x for Freshpet, Inc. — 30. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FRPT: 31. 4% to $73. 42.
08Which pays a better dividend — JBSS or IPAR or EL or FRPT?
In this comparison, IPAR (3.
4% yield), JBSS (2. 7% yield), EL (2. 0% yield) pay a dividend. FRPT does not pay a meaningful dividend and should not be held primarily for income.
09Is JBSS or IPAR or EL or FRPT better for a retirement portfolio?
For long-horizon retirement investors, John B.
Sanfilippo & Son, Inc. (JBSS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 31), 2. 7% yield, +101. 1% 10Y return). The Estée Lauder Companies Inc. (EL) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JBSS: +101. 1%, EL: +10. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between JBSS and IPAR and EL and FRPT?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: JBSS is a small-cap deep-value stock; IPAR is a small-cap deep-value stock; EL is a mid-cap quality compounder stock; FRPT is a small-cap quality compounder stock. JBSS, IPAR, EL pay a dividend while FRPT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.